11.13.17
Metrics Contract Services unveiled details about its new $80 million commercial manufacturing facility at AAPS 2017 in San Diego. Metrics is the contract development and manufacturing division of Mayne Pharma.
Construction of the company’s new oral solid-dose commercial manufacturing facility in Greenville, NC, is complete, with production beginning in January. This $80 million, 126,000-sq.-ft. facility quadruples the company’s U.S. manufacturing capacity.
The facility allows Metrics Contract Services to offer comprehensive development services from “concept to commercialization” in one location under one site registration. It offers larger scale and increased capabilities for scale-up, reducing the technical and regulatory complexity of site transfers.
This expansion includes commercial-scale, solvent-based, fluid-bed processing and film coating, a first for its operations in the U.S. With this new facility, Mayne Pharma will triple its worldwide fluid-bed processing capacity.
Construction of the company’s new oral solid-dose commercial manufacturing facility in Greenville, NC, is complete, with production beginning in January. This $80 million, 126,000-sq.-ft. facility quadruples the company’s U.S. manufacturing capacity.
The facility allows Metrics Contract Services to offer comprehensive development services from “concept to commercialization” in one location under one site registration. It offers larger scale and increased capabilities for scale-up, reducing the technical and regulatory complexity of site transfers.
This expansion includes commercial-scale, solvent-based, fluid-bed processing and film coating, a first for its operations in the U.S. With this new facility, Mayne Pharma will triple its worldwide fluid-bed processing capacity.
